StockDriftsStockDriftsTop 50 PSP Research LLC Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| XBI | SPDR SERIES TRUST | 48.01% | 570.0K | $90.2M | +100.07%(+285.10K) | $131.67(+20.00%) | 2026-06-30 | |
| SGOV | ISHARES TR | 37.51% | 700.0K | $70.5M | +0.00%(+0) | $100.54(+0.02%) | 2026-06-30 | |
| RPRX | ROYALTY PHARMA PLC | 0.33% | 11.0K | $617K | +0.00%(+0) | $36.96(+60.17%) | 2026-06-30 | |
| NRIX | NURIX THERAPEUTICS INC | 0.32% | 25.0K | $607K | -12.89%(-3.70K) | $14.10(+91.78%) | 2026-06-30 | |
| INCY | INCYTE CORP | 0.32% | 5.3K | $601K | +0.00%(+0) | $91.79(+30.91%) | 2026-06-30 | |
| ARGX | ARGENX SE | 0.32% | 641 | $595K | +0.00%(+0) | $789.19(+24.48%) | 2026-06-30 | |
| IRON | DISC MEDICINE INC | 0.31% | 8.0K | $585K | +0.00%(+0) | $71.68(+10.00%) | 2026-06-30 | |
| RAPP | RAPPORT THERAPEUTICS INC | 0.31% | 14.0K | $583K | +0.00%(+0) | $30.02(+57.96%) | 2026-06-30 | |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 0.3% | 17.0K | $568K | -23.08%(-5.10K) | $21.98(+19.91%) | 2026-06-30 | |
| TRVI | TREVI THERAPEUTICS INC | 0.3% | 30.0K | $560K | +0.00%(+0) | $12.23(+51.00%) | 2026-06-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative | Since First Filing (2 quarters) |
|---|---|---|---|---|---|
| Top 20 Holdings Weighted | — | — | — | — | +10.49% |
| Top 20 Holdings Unweighted | — | — | — | — | +32.88% |
PSP Research LLC reports $187.88M in US-listed equity holdings across 75 positions in its most recent 13F filing. Its largest disclosed positions are XBI (48.0%), SGOV (37.5%) and RPRX (0.3%). The top 20 holdings account for 90.83% of reported assets. Its disclosed equity book has returned +10.49% cumulatively over 2 quarters. Figures reflect the Q2 2026 filing.
Portfolio changes
Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.
Sign up free to track PSP Research LLC, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from PSP Research LLC’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 2106939). View PSP Research LLC’s 13F filings on SEC